Trial Information
A Randomized Phase II Study of Conventional 3D Radiation (3DCRT) Versus Intensity-Modulated Radiation (IMRT) in Squamous Cell Cancer of the Head and Neck (SCCHN): Pilot Feasibility Study
Inclusion Criteria:
- histologically proven squamous cell carcinoma of the head and neck or squamous cell
cancer to the neck from an unknown head and neck primary site, stage I-IV disease
which is M0, age greater than 18 years, KPS greater than 70, signed study-specific
consent
Exclusion Criteria:
- M1; bilateral N3 disease; primary greater than 10cm; salivary gland disease; life
expectancy less than 2 years; prior radiotherapy to the head and neck; no signed
study-specific consent form
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Prevalence and severity of side effects according to Radiation Therapy Oncology Group
Principal Investigator
Harold P Lau, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Tom Baker Cancer Center
Authority:
Canada: Health Canada
Study ID:
20313
NCT ID:
NCT00363441
Start Date:
Completion Date:
Related Keywords:
- Head and Neck Neoplasms
- Squamous Cell Cancer
- head and neck neoplasms
- squamous cell cancer
- intensity modulated radiotherapy
- Neoplasms
- Carcinoma, Squamous Cell
- Neoplasms, Squamous Cell
- Head and Neck Neoplasms